| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |